QUETIAPINE MEDIS XR quetiapine (as fumarate) 300mg modified release tablets blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

quetiapine fumarate, Quantity: 345.45 mg (Equivalent: quetiapine, Qty 300 mg)

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

Quetiapine fumarate

formulario farmacéutico:

Tablet, modified release

Composición:

Excipient Ingredients: sodium chloride; purified talc; magnesium stearate; lactose monohydrate; hypromellose; povidone; titanium dioxide; iron oxide yellow; macrogol 400

Vía de administración:

Oral

Unidades en paquete:

10, 30, 60, 100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Bipolar disorder,? Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes ? Treatment of depressive episodes associated with bipolar disorder (see DOSAGE AND ADMINISTRATION) ? Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate,Efficacy of quetiapine modified release tablets in the treatment of bipolar disorder indications was established in part, on the basis of extrapolation from the established effectiveness of quetiapine immediate release tablets.,Schizophrenia Treatment of schizophrenia, prevention of relapse and maintenance of clinical improvement during continuation therapy.,Major depressive disorder Treatment of recurrent major depressive disorder (MDD) in patients who are intolerant of, or who have an inadequate response to alternative therapies.,Generalised anxiety disorder Treatment of generalised anxiety disorder (GAD).

Resumen del producto:

Visual Identification: Light yellow coloured, round shaped, biconvex film coated tablets, debossed with 'Q300' on one side and plain on other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2016-03-21